Latest Articles
Endometrial Ablation Devices Market Size, Benefits, and Key Players - Latest Health Tech - openPR.com
Endometrial Ablation Devices Market Size, Benefits, and Key Players - Latest Health Tech openPR.com
Published: June 25, 2025, 6:07 a.m.
AZ redefines endometrial and ovarian cancer playbook - koreabiomed.com
AZ redefines endometrial and ovarian cancer playbook koreabiomed.com
Published: June 25, 2025, 12:05 a.m.
Molecular profiling reduces need for radiotherapy in endometrial cancer - Contemporary OB/GYN
Molecular profiling reduces need for radiotherapy in endometrial cancer Contemporary OB/GYN
Published: June 24, 2025, 5:47 p.m.
ASCO 2025: How Emerging Therapies Are Reshaping the Treatment Landscape in Endometrial Cancer - Medscape
ASCO 2025: How Emerging Therapies Are Reshaping the Treatment Landscape in Endometrial Cancer Medscape
Published: June 24, 2025, 3:51 p.m.
ASCO 2025: Reshaping the Landscape in Endometrial Cancer - Medscape
ASCO 2025: Reshaping the Landscape in Endometrial Cancer Medscape
Published: June 24, 2025, 3:51 p.m.
Can sleep disruption cause endometrial cancer? | Tap to know more | Inshorts - Inshorts
Can sleep disruption cause endometrial cancer? | Tap to know more | Inshorts Inshorts
Published: June 24, 2025, 8:01 a.m.
One Patient With Endometrial Cancer Reflects on the Most Important Lesson She Learned - Katie Couric Media
One Patient With Endometrial Cancer Reflects on the Most Important Lesson She Learned Katie Couric Media
Published: June 23, 2025, 8:03 p.m.
Computational image and molecular analysis reveal unique prognostic features of immune architecture in African Versus European American women with endometrial cancer - Nature
Computational image and molecular analysis reveal unique prognostic features of immune architecture in African Versus European American women with endometrial cancer Nature
Published: June 23, 2025, 7:30 a.m.
ARNTL-mediated INO80-DHX15 axis reprograms the glycolytic metabolism and augments the progression of endometrial carcinoma - Nature
ARNTL-mediated INO80-DHX15 axis reprograms the glycolytic metabolism and augments the progression of endometrial carcinoma Nature
Published: June 20, 2025, 8:06 p.m.
Cyclin D2 --a potential biomarker in uterine corpus endometrial carcinoma through methylation chip and bioinformatic analysis - Frontiers
Cyclin D2 --a potential biomarker in uterine corpus endometrial carcinoma through methylation chip and bioinformatic analysis Frontiers
Published: June 19, 2025, 10:09 p.m.
Link copied to clipboard!